High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.5M
$1,514,829
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-04 | $54,062 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-03-03 | $246,910 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2026-01-22 | $34,162 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-12-22 | $168,492 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -10.9%
|
2025-11-24 | $330,094 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-11-21 | $10,981 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-09 | $116,931 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-08 | $102,456 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 SellΔOwn -11.2%
|
2025-10-07 | $332,386 | S | Form 4 |
| BCAX |
Bicara Therapeutics Inc.
|
CFO
10b5-1 Sell
|
2025-10-06 | $118,356 | S | Form 4 |